Toggle navigation Home Team Team Media Collaborations Sponsors Acknowledgements Project Background Design CRISPR/Cas9 Strategy Experiments Notebook Results Perspective Interlab Study Parts Parts Basic Parts Composite Parts Human Pratices Overview Societal Issues of CRISPR/Cas9 Responsible Research and Innovation GMO regulation Integrated Practices Engagement Model Attributions Safety Contents 1 Wednesday 13th July 1.1 Lab work 1.1.1 Getting DNA closer 1.1.1.1 Glycerol stocks for DH5α tra,sformed with DS-NMcas, DS-SPcasN-, DS-ST1casN- and DS-TDcasN- 1.1.1.2 1.1.2 Biobrick characterization 1.1.2.1 BL21 electrocompetent cells preparation and transformation 1.1.3 Visualization 1.1.3.1 Wednesday 13th July Lab work Getting DNA closer Glycerol stocks for DH5α tra,sformed with DS-NMcas, DS-SPcasN-, DS-ST1casN- and DS-TDcasN- By Laetitia 8 stocks were made: 2 clones (Cl 1 and Cl 2) by cas: Cl1 and Cl2 of DS-NMcas Cl1 and Cl2 of DS-SPcasN- Cl1 and Cl2 of DS-ST1casN- Cl1 and Cl2 of DS-TDcasN- For 1 glycerol stock: 1mL of liquid culture 500 μL of glycerol 60% Biobrick characterization BL21 electrocompetent cells preparation and transformation By Mathilde and Charlène We did an electro-transformation of BL21 with : pcl_TAA + K1372001 (time constant equal to 5.9ms) pcl_TAG + K1372001 (time constant equal to 6 ms) pcl_Tq + K1372001 (time constant equal to 6 ms) Cells were displayed on LB + Streptomycin (50µg/mL) + Chloramphenicol (30µg/mL) medium. For each condition, we made a dish with 50µL of cells and another with 500µL of cells. Visualization
By Laetitia
8 stocks were made: 2 clones (Cl 1 and Cl 2) by cas:
For 1 glycerol stock: 1mL of liquid culture 500 μL of glycerol 60%
By Mathilde and Charlène
We did an electro-transformation of BL21 with :
Cells were displayed on LB + Streptomycin (50µg/mL) + Chloramphenicol (30µg/mL) medium. For each condition, we made a dish with 50µL of cells and another with 500µL of cells.
